This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
The synthesized 30 amino acid peptide (residues 705-734) from HCV E2 binds to dendritic cells via the DC-SIGN receptor, induces their maturation, increases IL-12, CD80, and CD86 production, decreases IL-10, and activates p38 MAPK signaling.
Why it matters
Understanding how HCV peptides activate immune cells helps identify new targets for vaccines or inhibitors, potentially improving hepatitis C treatment and prevention.
How the study worked
The study synthesized a 30 amino acid peptide from HCV E2 using solid-phase peptide synthesis. Western blot and infection blocking assays confirmed peptide characteristics. ELISA and flow cytometry assessed dendritic cell responses and T cell activation after peptide treatment.
What this study cannot tell us
The study did not specify the sample size or in vivo validation, limiting understanding of clinical relevance. The exact signaling mechanisms require further exploration.
Read the original research
Synthesized peptides 705-734 from hepatitis C virus E2 glycoprotein induce dendritic cell maturation by activating p38 MAPK signaling.
International immunopharmacology, 30, 194-201
Citation
Liu, Xiaojing; Chen, Na; Lin, Shumei; Liu, Min. (2016). Synthesized peptides 705-734 from hepatitis C virus E2 glycoprotein induce dendritic cell maturation by activating p38 MAPK signaling.. International immunopharmacology, 30, 194-201. https://doi.org/10.1016/j.intimp.2015.11.009